All GLG News Analyses Filed Under: Business of Medicine

If this indeed occurs it should be a great help to the cost of healthcare. Many drugs which remain on patent are clearly more expensive than generics. As the public becomes aware of this, the trust in Big Pharma will erode further.

The issues are several: A wave of disease infected and killed many Chinese pigs (whose intestines are raw source material for heparin) and this drove up prices while decreasing supply. Heparin is a low cost, generic drug requiring an extremely tight supply chain to keep costs down.  ...

Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families.  My grandpa used to call this stuff...

EHR should not be mandated unless the government steps in and picks up the majority of the costs to implement and maintain EHR in a physician practice. 

Meerck at this point has no major Cardiovascular contentender without issue. This is clearly bad for the company.

Medicare has launched a pilot online personal health records program in South Carolina.  This programs provides thousands of Medicare beneficiaries access to personal health records (PHRs) containing their hospital and physician claims information.  Although information on their prescription...

Issue: Risk of fraud motivated contamination, and vendor quality failures, could and should have been seen long in advance, and nearly every drug and device faces this threat.  Outsourcing Managers have been entirely cost driven, without exercising adequate management of supply chain...

Physician ranking systems will certainly be a part of medical practice. But the real utility is not going to be in allowing patients to choose the "best" doctors--that will perpetuate the fallacy of drawing conclusions about a specific case from the general data. And the ability of this information...

Ranking doctors and hospitals will certainly move the most profitable patients able to afford commercial health insurance AND travel.  Medical Providers who help set their (local) standards to affect real outcomes reporting regular consumers can understand will increase their market share. ...

Wal-Mart Stores (WMT) latest expansion of its generic drug program represents more of the same despite the company's promise on Friday to make a “major health care announcement.” Nonetheless, the company’s latest comments shed additional light on the true economics of the program. Here are some high...